Review of Drug Master Files in Advance of Certain ANDA Submissions Under GDUFA

[FDA]

This guidance is intended for holders of Type II active pharmaceutical ingredient (API) drug master files (DMFs) that will be referenced in an abbreviated new drug application (ANDA), or a prior approval supplement (PAS) to an ANDA.


Baca selengkapnya di : http://www.fda.gov...